Jayesh Mehta

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

Shaji Kumar, J H Lee, Juan José Lahuerta et al. · Leukemia · 2011 · 721 citations

Medicine, Hematology, Pharmacotherapy +15

Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial

R Powles, Jayesh Mehta, Samar Kulkarni et al. · The Lancet · 2000 · 355 citations

Medicine, Hematology, Oncology +14

Immune Reconstitution/Immunocompetence in Recipients of Kidney Plus Hematopoietic Stem/Facilitating Cell Transplants

Joseph R. Leventhal, Mary Jane Elliott, Esma S. Yolcu et al. · Transplantation · 2015 · 134 citations

Medicine, Immunology, Nephrology +17

Acyclovir to prevent reactivation of varicella zoster virus (herpes zoster) in multiple myeloma patients receiving bortezomib therapy

Eric Vickrey, Sharon Allen, Jayesh Mehta et al. · Cancer · 2008 · 107 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Yttrium-90 Ibritumomab Tiuxetan Doses Calculated to Deliver up to 15 Gy to Critical Organs May Be Safely Combined With High-Dose BEAM and Autologous Transplantation in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Jane N. Winter, David J. Inwards, Stewart Spies et al. · Journal of Clinical Oncology · 2009 · 99 citations · Full text

Medicine, Oncology, Radiation Oncology +17